FDA: Gabapentin, opioid combination may cause breathing problems

Friday, December 20, 2019 - 01:20 in Health & Medicine

New warnings about the risk of dangerous breathing difficulties when gabapentinoids are used with opioids or by certain patients must now appear on product labels, the U.S. Food and Drug Administration announced.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net